DHA- and EPA-Enriched Phosphatidylcholine Suppress Human Lung Carcinoma 95D Cells Metastasis via Activating the Peroxisome Proliferator-Activated Receptor γ

• Published in: Nutrients 2022-11, Vol.14 (21), p.4675
• Main Authors: Yin, Haowen, Liu, Yuanyuan, Yue, Hao, Tian, Yingying, Dong, Ping, Xue, Changhu, Zhao, Yun-Tao, Zhao, Zifang, Wang, Jingfeng
• Format: Article
• Language: English
• Subjects: Actin; AKT protein; Angiogenesis; Antibodies; Cancer; Carcinoma; Care and treatment; Cell adhesion & migration; Cell culture; Cell cycle; Cell growth; Cell proliferation; Chemokine receptors; Cofilin; Comparative analysis; CXCR4 protein; DHA-PC; Dietary supplements; Docosahexaenoic acid; Eicosapentaenoic acid; EPA-PC; Fatty acids; Gelatinase B; Growth factors; Health aspects; human lung carcinoma 95D cells; Immunofluorescence; Kinases; Lecithin; Lipids; Lung cancer; Lung carcinoma; Lungs; Matrix metalloproteinases; Metalloproteinase; Metastases; Metastasis; Molecular modelling; Muscle proteins; NF-κB protein; Omega-3 fatty acids; Peroxisome proliferator-activated receptors; Phosphatases; Phosphatidylcholine; Phospholipids; Physiological aspects; PPARγ; Prevention; Protein kinase; Proteins; PTEN protein; Signal transduction; Tensin; Unsaturated fatty acids; Vascular endothelial growth factor; Western blotting
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu14214675

The antineoplastic effects of docosahexaenoic acid-containing phosphatidylcholine (DHA-PC) and eicosapentaenoic acid-containing phosphatidylcholine (EPA-PC) were explored, and their underlying mechanisms in the human lung carcinoma 95D cells (95D cells) were investigated. After treatment of 95D cells with DHA-PC or EPA-PC, cell biological behaviors such as growth, adhesion, migration, and invasion were studied. Immunofluorescence and western blotting were carried out to assess underlying molecular mechanisms. Results showed that 95D cells proliferation and adherence in the DHA-PC or EPA-PC group were drastically inhibited than the control group. DHA-PC and EPA-PC suppressed the migration and invasion of 95D cells by disrupting intracellular F-actin, which drives cell movement. The protein expression of PPARγ was induced versus the control group. Furthermore, critical factors related to invasion, including matrix metallopeptidase 9 (MMP9), heparanase (Hpa), and vascular endothelial growth factor (VEGF), were drastically downregulated through the PPARγ/NF-κB signaling pathway. C-X-C chemokine receptor type 4 (CXCR4) and cofilin were significantly suppressed via DHA-PC and EPA-PC through the PPARγ/phosphatase and tensin homolog (PTEN)/serine-threonine protein kinase (AKT) signaling pathway. DHA-PC and EPA-PC reversed the PPARγ antagonist GW9662-induced reduction of 95D cells in migration and invasion capacity, suggesting that PPARγ was directly involved in the anti-metastasis efficacy of DHA-PC and EPA-PC. In conclusion, DHA-PC and EPA-PC have great potential for cancer therapy, and the antineoplastic effects involve the activation of PPARγ. EPA-PC showed more pronounced antineoplastic effects than DHA-PC, possibly due to the more robust activation of PPARγ by EPA-PC.